| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President | CFO And Head Of Strategy
2 companies
Kosaraju Sridhar is a President at PEN with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 34 sells.
Estimated insider holdings value: $51.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 30, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 1,500 | $150.38 | $225,568.95 | -33.3% | -50.5% | -75.8% | |
| Nov 24, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 1,500 | $150.06 | $225,084.45 | -25.0% | -47.9% | -76.3% | |
| Oct 25, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 1,500 | $166.32 | $249,477.74 | -4.4% | -43.9% | -84.3% | |
| Sep 23, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 1,500 | $159.04 | $238,561.99 | -8.5% | -7.7% | -81.8% | |
| Aug 23, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 1,500 | $162.06 | $243,087.50 | -3.0% | -9.7% | -78.4% | |
| Jul 23, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 1,500 | $183.67 | $275,500.35 | -3.3% | -10.7% | -80.9% | |
| Jun 23, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 1,500 | $199.95 | $299,923.18 | -2.9% | -20.1% | -76.9% | |
| May 24, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 1,500 | $161.16 | $241,746.00 | -2.6% | -1.5% | -72.5% | |
| Apr 23, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 1,500 | $193.08 | $289,623.12 | -1.9% | -4.2% | -72.2% | |
| Mar 23, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 1,500 | $174.63 | $261,939.00 | -2.9% | +13.6% | -60.8% |